Follow-On Biologics “Integrally Related” To Patent Reform Bill, Sen. Hatch Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Remarks suggest the potential for an alternate vehicle for addressing brand firms’ concerns about patent certainty, even as work on overall health care reform intensifies.